| Market Cap | ₹7,204Cr | 
| ROE | 3.77% | 
| P/E Ratio(TTM) | 64.85 | 
| EPS(TTM) | 5.68 | 
| P/B Ratio | 3.04 | 
| Dividend Yield | 0.14% | 
| Industry P/E | 34.63 | 
| Book Value | 121.29 | 
| Debt to Equity | 0.25 | 
| Face Value | 1 | 
| Parent Organisation | Shilpa Medicare Limited | 
| Managing Director | Mr. Vishnukant Bhutada | 
| NSE Symbol | SHILPAMED | 
| COMPANY | 52 WEEK  | MARKET PRICE | P/E Ratio  | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%)  | 61.33  | ||
| Gland Pharma | NA (0.00%)  | 42.19  | ||
| Ajanta Pharma | NA (0.00%)  | 32.58  | ||
| Eris Lifesciences | NA (0.00%)  | 52.95  |